CLS is committed to providing the media with timely and accurate information related to California’s life sciences ecosystem. CLS welcomes all media inquiries from news organizations and reporters. Members of the media interested in speaking with CLS opinion leaders on issues of public policy, life sciences innovation, or issues related to the life sciences ecosystem in California, please contact our communication department.
Media Contact: [email protected]
CLS has Partnered with San Diego Squared (SD2)
Sep 4, 2024
CLS has partnered with San Diego Squared (SD2) to support its mission to empower historically marginalized and underserved high school and college students who have demonstrated talent in a STEM field...
Read More
California Life Sciences Announces Five New Board Members
Aug 19, 2024
San Francisco, CA – California Life Sciences (CLS), the state’s most impactful life sciences membership organization advocating for the sector and its diverse innovation pipeline, today announced five new board members..
Read More
Statement from CLS CEO, Mike Guerra, on CMS Drug Pricing
Aug 15, 2024
Following the conclusion of an arbitrary process, CMS has released the drug prices for the first ten products selected for the Medicare Drug Price Negotiation Program with cuts to list..
Read More Resolution Introduced to Declare August 2024 as “Life Sciences Month” in California
Aug 7, 2024
August 7, 2024 Sacramento, CA – In partnership with California Life Sciences, Senator Catherine Blakespear (D-Oceanside), introduced SCR 111, declaring August as “Life Sciences Month” for the state of California. SCR..
Read More Nominations are now open for the 2024 Pantheon Awards
Jun 24, 2024
June 24, 2024 South San Francisco, Calif. – Nominations are open for the 21st annual Pantheon Awards—California’s largest awards show celebrating excellence in the life sciences. This year, California Life Sciences..
Read More CLS applauds yesterday’s decision by the Supreme Court to uphold the FDA’s review and approval authority for new medicines
Jun 14, 2024
CLS applauds yesterday’s decision by the Supreme Court to uphold the FDA’s review and approval authority for new medicines. The importance of regulatory certainty cannot be overstated for our innovative..
Read More